Table 5.
Supportive therapy for the study population at the onset of septic shock.
| Supportive Therapy | ET (n = 50) | ScT (n = 51) | p Value * |
|---|---|---|---|
| Respiratory Support | |||
| Any ventilation, n (%) | 50 (100) | 51 (100) | 1 |
| Non-invasive ventilation, n (%) | 3 (6) | 2 (4) | 0.67 |
| Mechanical ventilation, n (%) | 21 (42) | 31 (61) | 0.07 |
| High frequency oscillatory ventilation, n (%) | 26 (52) | 18 (35) | 0.11 |
| Oxygen requirement, n (%) | 46 (92) | 49 (96) | 0.4 |
| Inhaled nitric oxide, n (%) | 26 (52) | 21 (37) | 0.3 |
| Intravenous Fluid, n (%) | |||
| Any fluid, n (%) | 49 (98) | 49 (96) | – |
| Saline bolus, n (%) | 45 (90) | 44 (86) | 0.75 |
| Plasma bolus, n (%) | 27 (54) | 31 (61) | 0.55 |
| Inotropic Agents | |||
| Any inotropic agents, n (%) | 42 (84) | 45 (88) | 0.6 |
| Dopamine, n (%) | 40 (80) | 41 (80) | 1 |
| Dobutamine, n (%) | 35 (70) | 29 (57) | 0.2 |
| Epinephrine, n (%) | 9 (18) | 2 (4) | 0.03 |
| Hydrocortisone, n (%) | 25 (50) | 16 (31) | 0.07 |
* Chi-squared test for categorical variables, Mann–Whitney U test for quantitative variables; ET: Exchange transfusion; ScT: Standard care therapy. Bold number: p Value ≤ 0.05.